Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    Brucellosis:
    regionally emerging zoonotic disease? (2010)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Gwida, Mayada
    Al Dahouk, Sascha
    Melzer, Falk
    Rösler, Uwe
    Neubauer, Heinrich
    Tomaso, Herbert
    Quelle
    Croatian medical journal; 51(4) — S. 289–295
    ISSN: 0353-9504
    Sprache
    Englisch
    Verweise
    Pubmed: 20718081
    Kontakt
    Institut für Tier- und Umwelthygiene

    Robert-von-Ostertag-Str. 7-13
    Gebäude 35
    14169 Berlin
    Tel.+49 30 8385 1845 Fax.+49 30 83845 1863
    email:tierhygiene@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    To gain deeper insight into the seroprevalence of brucellosis, which remains a zoonotic disease of worldwide public health concern, by reviewing studies from countries including North Africa, the Middle East, and India.

    Studies on brucellosis performed in countries that are neighbors or important trading partners of the European Union and on trade animals and their products were analyzed. We reviewed 37 seroprevalence studies on brucellosis published from 1948 to 2009 retrieved from Pubmed, Google, and ScienceDirect.

    The set of studies was heterogeneous in the number of samples and laboratory tests used. We included studies from Algeria (n=1), Egypt (n=7), India (n=3), Iran (n=3), Iraq (n=1), Jordan (n=5), Libya (n=3), Saudi Arabia (n=3), Syria (n=1), Turkey (n=5), and Yemen (n=2). The total number of animals in these studies was 116317 (cattle 75375; buffalo 9644; sheep 10550; goats 14447; camels 6301). The prevalence of brucellosis in different animal species varied widely. Representative surveillance data have not recently been published in any of the countries.

    Wars in the Middle East, insufficient preventive measures, the lack of adequate control programs in some countries, as well as uncontrolled animal transportation through "open" borders increased the risk that brucellosis will spread in some regions. New seroprevalence data are needed urgently to evaluate the current situation and for continuous monitoring of necessary control programs.